Public Companies
Irwin Naturals Buys Keta Media
Marketing company expected to help clinic expansion.
The post Irwin Naturals Buys Keta Media appeared first on Green Market Report.
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) has acquired Keta Media, LLC, dba Ketamine Media as of March 17, 2023 in a deal initially announced in September 2022. While the amount paid for the company wasn’t disclosed, it was said to be all cash and that Irwin would assume certain debts of Keta Media. Ketamine Media is the nation’s foremost advertising company dedicated to raising awareness about the clinical use of ketamine.
“We are delighted to welcome the Ketamine Media team to the Irwin Naturals family,” said Klee Irwin, founder, and CEO of Irwin Naturals. “We believe that acquiring Ketamine Media will propel us to new heights in the ketamine therapy market, as we collaborate to deliver cutting-edge marketing solutions for our clients.”
The company said that the acquisition represented two significant milestones in Irwin’s growth strategy for its Emergence clinics in the mental health industry. “Firstly, the acquisition is anticipated to have a positive impact on the company’s annualized EBITDA. Secondly, the addition of this premier marketing agency showcases Irwin’s capacity to attract top-tier talent as it aims to establish the world’s largest network of psychedelic mental health clinics, said a company statement.
Through this acquisition, Irwin plans to expedite the establishment of new potential clinic locations and harness Ketamine Media’s expertise to enhance utilization rates at its existing and future Emergence clinics.
Irwin recently decided against acquiring Braxia Scientific. Last week, Green Market Report wrote that Klee Irwin said that the decision was made due to “a lack of a clear business rationale” for the company to close the deal. The CEO expressed disappointment but added that the decision was necessary for the company’s long-term growth and value creation. The company said it remains committed to exploring opportunities to drive a longer upside.
The post Irwin Naturals Buys Keta Media appeared first on Green Market Report.
ketamine psychedelic therapy cse otc deal capital braxia scientific braxia irwin naturals
-
Psilocybin1 week agoTulum vs. Oaxaca: The Tale of 2 Psychedelic Cities
-
Psychedelics1 week agoMissouri Considers $10 Million from Opioid Settlements for Psilocybin Research
-
Psychedelics6 days agoCybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
-
Law & Regulation6 days agoSynaptogenix increases psilocybin stake with PsygaBio
-
Psychedelics4 days agoThe EU’s Plan for a €6.5M Study of Psychedelics To Treat Mental Disorders
-
Psychedelics4 days agoExploring Psilocybin’s Potential in Diabetes Management
-
Law & Regulation6 days ago
Canada’s Optimi Health to ship psilocybin to New Zealand psychedelics research center
-
Psychedelics7 days agoOptimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute
